TGFBR2 and endometrial carcinoma: For instance, TGFBR2 mutational frequency is higher in MSI-H colon carcinomas (70 to 90%) than in MSI-H endometrium carcinoma (17 to 19%), suggesting that biological features and functional roles of target genes may differ depending on the tissue of tumor origin [33,34].